{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,26]],"date-time":"2026-10-26T17:36:59Z","timestamp":1793036219297,"version":"4.5.0"},"reference-count":66,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,2,6]],"date-time":"2024-02-06T00:00:00Z","timestamp":1707177600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2024,2,6]],"date-time":"2024-02-06T00:00:00Z","timestamp":1707177600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100007391","name":"Association pour la Recherche sur le Cancer","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007391","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004099","name":"Ligue Contre le Cancer","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004099","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001665","name":"Agence Nationale de la Recherche","doi-asserted-by":"publisher","award":["ANR-11-LABX-0028-01"],"award-info":[{"award-number":["ANR-11-LABX-0028-01"]}],"id":[{"id":"10.13039\/501100001665","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100006331","name":"Cancerop\u00f4le PACA","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100006331","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004792","name":"Minist\u00e8re de l'Enseignement Sup\u00e9rieur et de la Recherche","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004792","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100006364","name":"Institut National Du Cancer","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100006364","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Exp Clin Cancer Res"],"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>Angioimmunoblastic T-cell lymphoma (AITL) is a malignancy with very poor survival outcome, in urgent need of more specific therapeutic strategies. The drivers of malignancy in this disease are CD4<jats:sup>+<\/jats:sup> follicular helper T cells (Tfh). The metabolism of these malignant Tfh cells was not yet elucidated. Therefore, we decided to identify their metabolic requirements with the objective to propose a novel therapeutic option.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>To reveal the prominent metabolic pathways used by the AITL lymphoma cells, we relied on metabolomic and proteomic analysis of murine AITL (mAITL) T cells isolated from our established mAITL model. We confirmed these results using AITL patient and healthy T cell expression data.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>Strikingly, the mAITL Tfh cells were highly dependent on the second branch of the Kennedy pathway, the choline lipid pathway, responsible for the production of the major membrane constituent phosphatidylcholine. Moreover, gene expression data from Tfh cells isolated from AITL patient tumors, confirmed the upregulation of the choline lipid pathway. Several enzymes involved in this pathway such as choline kinase, catalyzing the first step in the phosphatidylcholine pathway, are upregulated in multiple tumors other than AITL. Here we showed that treatment of our mAITL preclinical mouse model with a fatty acid oxydation inhibitor, significantly increased their survival and even reverted the exhausted CD8 T cells in the tumor into potent cytotoxic anti-tumor cells. Specific inhibition of Chok\u03b1 confirmed the importance of the phosphatidylcholine production pathway in neoplastic CD4\u2009+\u2009T cells, nearly eradicating mAITL Tfh cells from the tumors. Finally, the same inhibitor induced in human AITL lymphoma biopsies cell death of the majority of the hAITL PD-1<jats:sup>high<\/jats:sup> neoplastic cells.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusion<\/jats:title>\n                <jats:p>Our results suggest that interfering with choline metabolism in AITL reveals a specific metabolic vulnerability and might represent a new therapeutic strategy for these patients.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s13046-024-02952-w","type":"journal-article","created":{"date-parts":[[2024,2,6]],"date-time":"2024-02-06T09:02:15Z","timestamp":1707210135000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":14,"title":["Inhibition of choline metabolism in an angioimmunoblastic T-cell lymphoma preclinical model reveals a new metabolic vulnerability as possible target for treatment"],"prefix":"10.1186","volume":"43","author":[{"given":"Adrien","family":"Krug","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marie","family":"Tosolini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Blandine","family":"Madji Hounoum","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean-Jacques","family":"Fourni\u00e9","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roger","family":"Geiger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matteo","family":"Pecoraro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patrick","family":"Emond","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Philippe","family":"Gaulard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fran\u00e7ois","family":"Lemonnier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean-Ehrland","family":"Ricci","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9224-5491","authenticated-orcid":false,"given":"Els","family":"Verhoeyen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,2,6]]},"reference":[{"issue":"9","key":"2952_CR1","doi-asserted-by":"publisher","first-page":"1095","DOI":"10.1182\/blood-2016-09-692541","volume":"129","author":"MA Lunning","year":"2017","unstructured":"Lunning MA, Vose JM. Angioimmunoblastic T-cell lymphoma: the many-faced lymphoma. Blood. 2017;129(9):1095\u2013102.","journal-title":"Blood."},{"issue":"11","key":"2952_CR2","doi-asserted-by":"publisher","first-page":"4952","DOI":"10.1182\/blood-2006-10-055145","volume":"109","author":"L de Leval","year":"2007","unstructured":"de Leval L, Rickman DS, Thielen C, de Reynies A, Huang YL, Delsol G, et al. The gene expression profile of nodal peripheral T-cell lymphoma demonstrates a molecular link between angioimmunoblastic T-cell lymphoma (AITL) and follicular helper T (TFH) cells. Blood. 2007;109(11):4952\u201363.","journal-title":"Blood."},{"issue":"2","key":"2952_CR3","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1016\/j.critrevonc.2009.01.002","volume":"72","author":"L de Leval","year":"2009","unstructured":"de Leval L, Bisig B, Thielen C, Boniver J, Gaulard P. Molecular classification of T-cell lymphomas. Crit Rev Oncol Hematol. 2009;72(2):125\u201343.","journal-title":"Crit Rev Oncol Hematol"},{"issue":"5","key":"2952_CR4","doi-asserted-by":"publisher","first-page":"673","DOI":"10.1111\/j.1365-2141.2009.08003.x","volume":"148","author":"L de Leval","year":"2010","unstructured":"de Leval L, Gisselbrecht C, Gaulard P. Advances in the understanding and management of angioimmunoblastic T-cell lymphoma. Br J Haematol. 2010;148(5):673\u201389.","journal-title":"Br J Haematol"},{"issue":"2","key":"2952_CR5","doi-asserted-by":"publisher","first-page":"240","DOI":"10.1200\/JCO.2011.37.3647","volume":"31","author":"M Federico","year":"2013","unstructured":"Federico M, Rudiger T, Bellei M, Nathwani BN, Luminari S, Coiffier B, et al. Clinicopathologic characteristics of angioimmunoblastic T-cell lymphoma: analysis of the international peripheral T-cell lymphoma project. J Clin Oncol. 2013;31(2):240\u20136.","journal-title":"J Clin Oncol."},{"issue":"10","key":"2952_CR6","doi-asserted-by":"publisher","first-page":"2392","DOI":"10.3390\/cancers14102392","volume":"14","author":"A Krug","year":"2022","unstructured":"Krug A, Tari G, Saidane A, Gaulard P, Ricci JE, Lemonnier F, et al. Novel T Follicular Helper-like T-Cell Lymphoma Therapies: From Preclinical Evaluation to Clinical Reality. Cancers (Basel). 2022;14(10):2392.","journal-title":"Cancers (Basel)."},{"issue":"6","key":"2952_CR7","doi-asserted-by":"publisher","first-page":"1312","DOI":"10.1016\/j.immuni.2016.03.016","volume":"44","author":"ML Balmer","year":"2016","unstructured":"Balmer ML, Ma EH, Bantug GR, Gr\u00e4hlert J, Pfister S, Glatter T, et al. Memory CD8(+) T Cells Require Increased Concentrations of Acetate Induced by Stress for Optimal Function. Immunity. 2016;44(6):1312\u201324.","journal-title":"Immunity."},{"issue":"6","key":"2952_CR8","doi-asserted-by":"publisher","first-page":"1239","DOI":"10.1016\/j.cell.2013.05.016","volume":"153","author":"CH Chang","year":"2013","unstructured":"Chang CH, Curtis JD, Maggi LB, Faubert B, Villarino AV, O\u2019Sullivan D, et al. Posttranscriptional control of T cell effector function by aerobic glycolysis. Cell. 2013;153(6):1239\u201351.","journal-title":"Cell."},{"issue":"3","key":"2952_CR9","doi-asserted-by":"publisher","first-page":"268","DOI":"10.1016\/j.ccell.2019.07.008","volume":"36","author":"L Mondrag\u00f3n","year":"2019","unstructured":"Mondrag\u00f3n L, Mhaidly R, De Donatis GM, Tosolini M, Dao P, Martin AR, et al. GAPDH Overexpression in the T Cell Lineage Promotes Angioimmunoblastic T Cell Lymphoma through an NF-\u03baB-Dependent Mechanism. Cancer Cell. 2019;36(3):268\u2013287.e10.","journal-title":"Cancer Cell."},{"issue":"8","key":"2952_CR10","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1038\/s41389-020-00259-x","volume":"9","author":"R Mhaidly","year":"2020","unstructured":"Mhaidly R, Krug A, Gaulard P, Lemonnier F, Ricci JE, Verhoeyen E. New preclinical models for angioimmunoblastic T-cell lymphoma: filling the GAP. Oncogenesis. 2020;9(8):73.","journal-title":"Oncogenesis."},{"key":"2952_CR11","doi-asserted-by":"publisher","first-page":"182","DOI":"10.1111\/bjh.18941","volume":"203","author":"A Mart\u00edn Garc\u00eda-Sancho","year":"2023","unstructured":"Mart\u00edn Garc\u00eda-Sancho A, Rodr\u00edguez-Pinilla SM, Domingo-Domenech E, Climent F, S\u00e1nchez-Garcia J, L\u00f3pez Jim\u00e9nez J, et al. Peripheral T-cell lymphoma with a T follicular-helper phenotype: A different entity? Results of the Spanish Real-T study. Br J Haematol. 2023;203:182\u201393.","journal-title":"Br J Haematol."},{"key":"2952_CR12","doi-asserted-by":"publisher","first-page":"323","DOI":"10.1186\/1471-2105-12-323","volume":"12","author":"B Li","year":"2011","unstructured":"Li B, Dewey CN. RSEM: accurate transcript quantification from RNA-Seq data with or without a reference genome. BMC Bioinformatics. 2011;12:323.","journal-title":"BMC Bioinformatics."},{"issue":"D1","key":"2952_CR13","doi-asserted-by":"publisher","first-page":"D687","DOI":"10.1093\/nar\/gkab1028","volume":"50","author":"M Gillespie","year":"2022","unstructured":"Gillespie M, Jassal B, Stephan R, Milacic M, Rothfels K, Senff-Ribeiro A, et al. The reactome pathway knowledgebase 2022. Nucleic Acids Res. 2022;50(D1):D687\u201392.","journal-title":"Nucleic Acids Res."},{"issue":"43","key":"2952_CR14","doi-asserted-by":"publisher","first-page":"15545","DOI":"10.1073\/pnas.0506580102","volume":"102","author":"A Subramanian","year":"2005","unstructured":"Subramanian A, Tamayo P, Mootha VK, Mukherjee S, Ebert BL, Gillette MA, et al. Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles. Proc Natl Acad Sci U S A. 2005;102(43):15545\u201350.","journal-title":"Proc Natl Acad Sci U S A."},{"issue":"7869","key":"2952_CR15","doi-asserted-by":"publisher","first-page":"724","DOI":"10.1038\/s41586-021-03692-z","volume":"595","author":"G Fu","year":"2021","unstructured":"Fu G, Guy CS, Chapman NM, Palacios G, Wei J, Zhou P, et al. Metabolic control of TFH cells and humoral immunity by phosphatidylethanolamine. Nature. 2021;595(7869):724\u20139.","journal-title":"Nature"},{"key":"2952_CR16","doi-asserted-by":"publisher","first-page":"1177590","DOI":"10.3389\/fonc.2023.1177590","volume":"13","author":"LA de PC Lage","year":"2023","unstructured":"de PC Lage LA, Culler HF, Reichert CO, da Siqueira SAC, Pereira J. Angioimmunoblastic T-cell lymphoma and correlated neoplasms with T-cell follicular helper phenotype: from molecular mechanisms to therapeutic advances. Front Oncol. 2023;13:1177590.","journal-title":"Front Oncol."},{"issue":"6","key":"2952_CR17","doi-asserted-by":"publisher","first-page":"414","DOI":"10.1002\/iub.337","volume":"62","author":"F Gibellini","year":"2010","unstructured":"Gibellini F, Smith TK. The Kennedy pathway\u2013De novo synthesis of phosphatidylethanolamine and phosphatidylcholine. IUBMB Life. 2010;62(6):414\u201328.","journal-title":"IUBMB Life"},{"issue":"8","key":"2952_CR18","doi-asserted-by":"publisher","first-page":"1256","DOI":"10.1002\/1873-3468.12919","volume":"592","author":"CR McMaster","year":"2018","unstructured":"McMaster CR. From yeast to humans - roles of the Kennedy pathway for phosphatidylcholine synthesis. FEBS Lett avr. 2018;592(8):1256\u201372.","journal-title":"FEBS Lett avr"},{"issue":"9 Pt B","key":"2952_CR19","doi-asserted-by":"publisher","first-page":"1558","DOI":"10.1016\/j.bbamem.2017.04.006","volume":"1859","author":"JN van der Veen","year":"2017","unstructured":"van der Veen JN, Kennelly JP, Wan S, Vance JE, Vance DE, Jacobs RL. The critical role of phosphatidylcholine and phosphatidylethanolamine metabolism in health and disease. Biochim Biophys Acta Biomembr. 2017;1859(9 Pt B):1558\u201372.","journal-title":"Biochim Biophys Acta Biomembr."},{"issue":"2","key":"2952_CR20","doi-asserted-by":"publisher","first-page":"e77","DOI":"10.1016\/j.clml.2021.08.013","volume":"22","author":"Z Han","year":"2022","unstructured":"Han Z, Xu H, Zhao M, Jing F, Xue H, Xiao S. Diabetes and the Prognosis in Patients With Non-Hodgkin Lymphoma: A Meta-analysis of Cohort Studies. Clin Lymphoma Myeloma Leuk. 2022;22(2):e77\u201388.","journal-title":"Clin Lymphoma Myeloma Leuk"},{"issue":"12","key":"2952_CR21","doi-asserted-by":"publisher","first-page":"835","DOI":"10.1038\/nrc3162","volume":"11","author":"K Glunde","year":"2011","unstructured":"Glunde K, Bhujwalla ZM, Ronen SM. Choline metabolism in malignant transformation. Nat Rev Cancer. 2011;11(12):835\u201348.","journal-title":"Nat Rev Cancer."},{"key":"2952_CR22","doi-asserted-by":"publisher","first-page":"266","DOI":"10.3389\/fonc.2016.00266","volume":"6","author":"M Cheng","year":"2016","unstructured":"Cheng M, Bhujwalla ZM, Glunde K. Targeting Phospholipid Metabolism in Cancer. Front Oncol. 2016;6:266.","journal-title":"Front Oncol"},{"issue":"2","key":"2952_CR23","doi-asserted-by":"publisher","first-page":"459","DOI":"10.4049\/jimmunol.1900658","volume":"204","author":"S Gokhale","year":"2020","unstructured":"Gokhale S, Lu W, Zhu S, Liu Y, Hart RP, Rabinowitz JD, et al. Elevated Choline Kinase \u03b1-Mediated Choline Metabolism Supports the Prolonged Survival of TRAF3-Deficient B Lymphocytes. J Immunol. 2020;204(2):459\u201371.","journal-title":"J Immunol."},{"key":"2952_CR24","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1016\/j.plipres.2016.03.005","volume":"63","author":"SP Arlauckas","year":"2016","unstructured":"Arlauckas SP, Popov AV, Delikatny EJ. Choline kinase alpha-Putting the ChoK-hold on tumor metabolism. Prog Lipid Res. 2016;63:28\u201340.","journal-title":"Prog Lipid Res"},{"issue":"7","key":"2952_CR25","doi-asserted-by":"publisher","first-page":"5473","DOI":"10.1007\/s13277-015-3214-8","volume":"36","author":"E Abdelzaher","year":"2015","unstructured":"Abdelzaher E, Mostafa MF. Lysophosphatidylcholine acyltransferase 1 (LPCAT1) upregulation in breast carcinoma contributes to tumor progression and predicts early tumor recurrence. Tumour Biol. 2015;36(7):5473\u201383.","journal-title":"Tumour Biol"},{"issue":"6","key":"2952_CR26","doi-asserted-by":"publisher","first-page":"1001","DOI":"10.1016\/j.molonc.2013.07.009","volume":"7","author":"K Grupp","year":"2013","unstructured":"Grupp K, Sanader S, Sirma H, Simon R, Koop C, Prien K, et al. High lysophosphatidylcholine acyltransferase 1 expression independently predicts high risk for biochemical recurrence in prostate cancers. Mol Oncol. 2013;7(6):1001\u201311.","journal-title":"Mol Oncol"},{"key":"2952_CR27","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1007\/978-981-19-0394-6_7","volume":"1372","author":"XC Jiang","year":"2022","unstructured":"Jiang XC, Chiang YP. Sphingomyelin Synthase Family and Phospholipase Cs. Adv Exp Med Biol. 2022;1372:77\u201386.","journal-title":"Adv Exp Med Biol"},{"issue":"3","key":"2952_CR28","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1038\/bcj.2015.10","volume":"5","author":"J Xiong","year":"2015","unstructured":"Xiong J, Bian J, Wang L, Zhou JY, Wang Y, Zhao Y, et al. Dysregulated choline metabolism in T-cell lymphoma: role of choline kinase-\u03b1 and therapeutic targeting. Blood Cancer J. 2015;5(3):287.","journal-title":"Blood Cancer J."},{"issue":"30","key":"2952_CR29","doi-asserted-by":"publisher","first-page":"3370","DOI":"10.1038\/onc.2011.51","volume":"30","author":"BF Clem","year":"2011","unstructured":"Clem BF, Clem AL, Yalcin A, Goswami U, Arumugam S, Telang S, et al. A novel small molecule antagonist of choline kinase-\u03b1 that simultaneously suppresses MAPK and PI3K\/AKT signaling. Oncogene. 2011;30(30):3370\u201380.","journal-title":"Oncogene."},{"issue":"13","key":"2952_CR30","doi-asserted-by":"publisher","first-page":"5647","DOI":"10.1158\/0008-5472.CAN-04-4416","volume":"65","author":"A Ramirez de Molina","year":"2005","unstructured":"Ramirez de Molina A, Gallego-Ortega D, Sarmentero J, Ba\u00f1ez-Coronel M, Mart\u00edn-Cantalejo Y, Lacal JC. Choline kinase is a novel oncogene that potentiates RhoA-induced carcinogenesis. Cancer Res. 2005;65(13):5647\u201353.","journal-title":"Cancer Res."},{"issue":"2","key":"2952_CR31","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1038\/ng.2872","volume":"46","author":"M Sakata-Yanagimoto","year":"2014","unstructured":"Sakata-Yanagimoto M, Enami T, Yoshida K, Shiraishi Y, Ishii R, Miyake Y, et al. Somatic RHOA mutation in angioimmunoblastic T cell lymphoma. Nat Genet. 2014;46(2):171\u20135.","journal-title":"Nat Genet"},{"issue":"10","key":"2952_CR32","doi-asserted-by":"publisher","first-page":"1024","DOI":"10.1158\/2159-8290.CD-15-0507","volume":"5","author":"ZE Stine","year":"2015","unstructured":"Stine ZE, Walton ZE, Altman BJ, Hsieh AL, Dang CV. MYC, Metabolism, and Cancer. Cancer Discov. 2015;5(10):1024\u201339.","journal-title":"Cancer Discov"},{"issue":"29","key":"2952_CR33","doi-asserted-by":"publisher","first-page":"10450","DOI":"10.1073\/pnas.1409778111","volume":"111","author":"LS Eberlin","year":"2014","unstructured":"Eberlin LS, Gabay M, Fan AC, Gouw AM, Tibshirani RJ, Felsher DW, et al. Alteration of the lipid profile in lymphomas induced by MYC overexpression. Proc Natl Acad Sci U S A. 2014;111(29):10450\u20135.","journal-title":"Proc Natl Acad Sci U S A."},{"issue":"7","key":"2952_CR34","doi-asserted-by":"publisher","first-page":"e0","DOI":"10.1038\/bcj.2017.61","volume":"7","author":"J Xiong","year":"2017","unstructured":"Xiong J, Wang L, Fei XC, Jiang XF, Zheng Z, Zhao Y, et al. MYC is a positive regulator of choline metabolism and impedes mitophagy-dependent necroptosis in diffuse large B-cell lymphoma. Blood Cancer J. 2017;7(7):e0.","journal-title":"Blood Cancer J."},{"issue":"6","key":"2952_CR35","doi-asserted-by":"publisher","first-page":"726","DOI":"10.1016\/j.bbabio.2010.10.022","volume":"1807","author":"LS Pike","year":"2011","unstructured":"Pike LS, Smift AL, Croteau NJ, Ferrick DA, Wu M. Inhibition of fatty acid oxidation by etomoxir impairs NADPH production and increases reactive oxygen species resulting in ATP depletion and cell death in human glioblastoma cells. Biochim Biophys Acta. 2011;1807(6):726\u201334.","journal-title":"Biochim Biophys Acta"},{"issue":"5","key":"2952_CR36","doi-asserted-by":"publisher","first-page":"e2226","DOI":"10.1038\/cddis.2016.132","volume":"7","author":"Q Qu","year":"2016","unstructured":"Qu Q, Zeng F, Liu X, Wang QJ, Deng F. Fatty acid oxidation and carnitine palmitoyltransferase I: emerging therapeutic targets in cancer. Cell Death Dis. 2016;7(5):e2226.","journal-title":"Cell Death Dis."},{"issue":"435","key":"2952_CR37","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1016\/j.canlet.2018.08.006","volume":"28","author":"Y Ma","year":"2018","unstructured":"Ma Y, Temkin SM, Hawkridge AM, Guo C, Wang W, Wang XY, et al. Fatty acid oxidation: An emerging facet of metabolic transformation in cancer. Cancer Lett. 2018;28(435):92\u2013100.","journal-title":"Cancer Lett"},{"issue":"15","key":"2952_CR38","doi-asserted-by":"publisher","first-page":"1745","DOI":"10.1042\/CS20190587","volume":"133","author":"S Cheng","year":"2019","unstructured":"Cheng S, Wang G, Wang Y, Cai L, Qian K, Ju L, et al. Fatty acid oxidation inhibitor etomoxir suppresses tumor progression and induces cell cycle arrest via PPAR\u03b3-mediated pathway in bladder cancer. Clin Sci (Lond). 2019;133(15):1745\u201358.","journal-title":"Clin Sci (Lond)"},{"issue":"4","key":"2952_CR39","doi-asserted-by":"publisher","first-page":"427","DOI":"10.1038\/nm.4055","volume":"22","author":"R Camarda","year":"2016","unstructured":"Camarda R, Zhou AY, Kohnz RA, Balakrishnan S, Mahieu C, Anderton B, et al. Inhibition of fatty acid oxidation as a therapy for MYC-overexpressing triple-negative breast cancer. Nat Med. 2016;22(4):427\u201332.","journal-title":"Nat Med"},{"issue":"1","key":"2952_CR40","doi-asserted-by":"publisher","first-page":"142","DOI":"10.1172\/JCI38942","volume":"120","author":"I Samudio","year":"2010","unstructured":"Samudio I, Harmancey R, Fiegl M, Kantarjian H, Konopleva M, Korchin B, et al. Pharmacologic inhibition of fatty acid oxidation sensitizes human leukemia cells to apoptosis induction. J Clin Invest. 2010;120(1):142\u201356.","journal-title":"J Clin Invest"},{"issue":"6","key":"2952_CR41","doi-asserted-by":"publisher","first-page":"5988","DOI":"10.3390\/ijms24065988","volume":"24","author":"C Lo Presti","year":"2023","unstructured":"Lo Presti C, Yamaryo-Bott\u00e9 Y, Mondet J, Berthier S, Nutiu D, Bott\u00e9 C, et al. Variation in Lipid Species Profiles among Leukemic Cells Significantly Impacts Their Sensitivity to the Drug Targeting of Lipid Metabolism and the Prognosis of AML Patients. Int J Mol Sci. 2023;24(6):5988.","journal-title":"Int J Mol Sci."},{"issue":"1","key":"2952_CR42","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1042\/cs0990027","volume":"99","author":"S Schmidt-Schweda","year":"2000","unstructured":"Schmidt-Schweda S, Holubarsch C. First clinical trial with etomoxir in patients with chronic congestive heart failure. Clin Sci (Lond). 2000;99(1):27\u201335.","journal-title":"Clin Sci (Lond)."},{"issue":"3","key":"2952_CR43","doi-asserted-by":"publisher","first-page":"504","DOI":"10.1016\/j.cmet.2018.06.002","volume":"28","author":"B Raud","year":"2018","unstructured":"Raud B, Roy DG, Divakaruni AS, Tarasenko TN, Franke R, Ma EH, et al. Etomoxir Actions on Regulatory and Memory T Cells Are Independent of Cpt1a-Mediated Fatty Acid Oxidation. Cell Metab. 2018;28(3):504\u2013515.e7.","journal-title":"Cell Metab."},{"issue":"1","key":"2952_CR44","doi-asserted-by":"publisher","first-page":"6289","DOI":"10.1038\/s41598-018-24676-6","volume":"8","author":"RS O\u2019Connor","year":"2018","unstructured":"O\u2019Connor RS, Guo L, Ghassemi S, Snyder NW, Worth AJ, Weng L, et al. The CPT1a inhibitor, etomoxir induces severe oxidative stress at commonly used concentrations. Sci Rep. 2018;8(1):6289.","journal-title":"Sci Rep."},{"key":"2952_CR45","doi-asserted-by":"publisher","first-page":"633210","DOI":"10.3389\/fonc.2021.633210","volume":"11","author":"KJ McKelvey","year":"2021","unstructured":"McKelvey KJ, Wilson EB, Short S, Melcher AA, Biggs M, Diakos CI, et al. Glycolysis and Fatty Acid Oxidation Inhibition Improves Survival in Glioblastoma. Front Oncol. 2021;11:633210.","journal-title":"Front Oncol"},{"issue":"5","key":"2952_CR46","doi-asserted-by":"publisher","first-page":"639","DOI":"10.1016\/S0306-3623(97)00301-7","volume":"30","author":"JG McCormack","year":"1998","unstructured":"McCormack JG, Stanley WC, Wolff AA. Ranolazine: a novel metabolic modulator for the treatment of angina. Gen Pharmacol. 1998;30(5):639\u201345.","journal-title":"Gen Pharmacol"},{"issue":"9","key":"2952_CR47","doi-asserted-by":"publisher","first-page":"1544","DOI":"10.1038\/s42255-023-00861-4","volume":"5","author":"M Redondo-Mu\u00f1oz","year":"2023","unstructured":"Redondo-Mu\u00f1oz M, Rodriguez-Baena FJ, Aldaz P, Caball\u00e9-Mestres A, Moncho-Amor V, Otaegi-Ugartemendia M, et al. Metabolic rewiring induced by ranolazine improves melanoma responses to targeted therapy and immunotherapy. Nat Metab. 2023;5(9):1544\u201362.","journal-title":"Nat Metab"},{"issue":"4","key":"2952_CR48","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1042\/CS20060307","volume":"113","author":"CJF Holubarsch","year":"2007","unstructured":"Holubarsch CJF, Rohrbach M, Karrasch M, Boehm E, Polonski L, Ponikowski P, et al. A double-blind randomized multicentre clinical trial to evaluate the efficacy and safety of two doses of etomoxir in comparison with placebo in patients with moderate congestive heart failure: the ERGO (etomoxir for the recovery of glucose oxidation) study. Clin Sci (Lond). 2007;113(4):205\u201312.","journal-title":"Clin Sci (Lond)."},{"issue":"50","key":"2952_CR49","doi-asserted-by":"publisher","first-page":"8247","DOI":"10.1038\/sj.onc.1208045","volume":"23","author":"A Rodr\u00edguez-Gonz\u00e1lez","year":"2004","unstructured":"Rodr\u00edguez-Gonz\u00e1lez A, Ramirez de Molina A, Fern\u00e1ndez F, Lacal JC. Choline kinase inhibition induces the increase in ceramides resulting in a highly specific and selective cytotoxic antitumoral strategy as a potential mechanism of action. Oncogene. 2004;23(50):8247\u201359.","journal-title":"Oncogene."},{"issue":"7","key":"2952_CR50","doi-asserted-by":"publisher","first-page":"1539","DOI":"10.1002\/ijc.29517","volume":"137","author":"E Marien","year":"2015","unstructured":"Marien E, Meister M, Muley T, Fieuws S, Bordel S, Derua R, et al. Non-small cell lung cancer is characterized by dramatic changes in phospholipid profiles. Int J Cancer. 2015;137(7):1539\u201348.","journal-title":"Int J Cancer."},{"key":"2952_CR51","doi-asserted-by":"publisher","first-page":"577420","DOI":"10.3389\/fonc.2020.577420","volume":"10","author":"LP Fern\u00e1ndez","year":"2020","unstructured":"Fern\u00e1ndez LP, Gomez de Cedr\u00f3n M, Ramirez de Molina A. Alterations of Lipid Metabolism in Cancer: Implications in Prognosis and Treatment. Front Oncol. 2020;10:577420.","journal-title":"Front Oncol."},{"issue":"1","key":"2952_CR52","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1016\/j.advenzreg.2010.09.010","volume":"51","author":"D Gallego-Ortega","year":"2011","unstructured":"Gallego-Ortega D, Gomez del Pulgar T, Vald\u00e9s-Mora F, Cebri\u00e1n A, Lacal JC. Involvement of human choline kinase alpha and beta in carcinogenesis: a different role in lipid metabolism and biological functions. Adv Enzyme Regul. 2011;51(1):183\u201394.","journal-title":"Adv Enzyme Regul."},{"issue":"2","key":"2952_CR53","doi-asserted-by":"publisher","first-page":"902","DOI":"10.1002\/med.21746","volume":"41","author":"B Rubio-Ruiz","year":"2021","unstructured":"Rubio-Ruiz B, Serr\u00e1n-Aguilera L, Hurtado-Guerrero R, Conejo-Garc\u00eda A. Recent advances in the design of choline kinase \u03b1 inhibitors and the molecular basis of their inhibition. Med Res Rev. 2021;41(2):902\u201327.","journal-title":"Med Res Rev"},{"issue":"10","key":"2952_CR54","doi-asserted-by":"publisher","first-page":"1169","DOI":"10.2174\/092986706776360923","volume":"13","author":"S Janardhan","year":"2006","unstructured":"Janardhan S, Srivani P, Sastry GN. Choline kinase: an important target for cancer. Curr Med Chem. 2006;13(10):1169\u201386.","journal-title":"Curr Med Chem"},{"issue":"6","key":"2952_CR55","doi-asserted-by":"publisher","first-page":"788","DOI":"10.3390\/pharmaceutics13060788","volume":"13","author":"JC Lacal","year":"2021","unstructured":"Lacal JC, Zimmerman T, Campos JM. Choline Kinase: An Unexpected Journey for a Precision Medicine Strategy in Human Diseases. Pharmaceutics. 2021;13(6):788.","journal-title":"Pharmaceutics."},{"issue":"6769","key":"2952_CR56","doi-asserted-by":"publisher","first-page":"503","DOI":"10.1038\/35000501","volume":"403","author":"AA Alizadeh","year":"2000","unstructured":"Alizadeh AA, Eisen MB, Davis RE, Ma C, Lossos IS, Rosenwald A, et al. Distinct types of diffuse large B-cell lymphoma identified by gene expression profiling. Nature. 2000;403(6769):503\u201311.","journal-title":"Nature."},{"issue":"10","key":"2952_CR57","doi-asserted-by":"publisher","first-page":"2251","DOI":"10.1084\/jem.20080809","volume":"205","author":"V Brune","year":"2008","unstructured":"Brune V, Tiacci E, Pfeil I, D\u00f6ring C, Eckerle S, van Noesel CJM, et al. Origin and pathogenesis of nodular lymphocyte-predominant Hodgkin lymphoma as revealed by global gene expression analysis. J Exp Med. 2008;205(10):2251\u201368.","journal-title":"J Exp Med."},{"issue":"11","key":"2952_CR58","doi-asserted-by":"publisher","first-page":"2129","DOI":"10.1038\/leu.2009.161","volume":"23","author":"S Eckerle","year":"2009","unstructured":"Eckerle S, Brune V, D\u00f6ring C, Tiacci E, Bohle V, Sundstr\u00f6m C, et al. Gene expression profiling of isolated tumour cells from anaplastic large cell lymphomas: insights into its cellular origin, pathogenesis and relation to Hodgkin lymphoma. Leukemia. 2009;23(11):2129\u201338.","journal-title":"Leukemia"},{"issue":"10","key":"2952_CR59","doi-asserted-by":"publisher","first-page":"391","DOI":"10.3390\/cancers10100391","volume":"10","author":"E Mariotto","year":"2018","unstructured":"Mariotto E, Viola G, Ronca R, Persano L, Aveic S, Bhujwalla ZM, et al. Choline Kinase Alpha Inhibition by EB-3D Triggers Cellular Senescence, Reduces Tumor Growth and Metastatic Dissemination in Breast Cancer. Cancers (Basel). 2018;10(10):391.","journal-title":"Cancers (Basel)."},{"key":"2952_CR60","doi-asserted-by":"publisher","DOI":"10.1089\/cbr.2021.0294","author":"Y Zou","year":"2021","unstructured":"Zou Y, Huang L, Sun S, Yue F, Li Z, Ma Y, et al. Choline kinase alpha promoted glioma development by activating PI3K\/AKT signaling pathway. Cancer Biother Radiopharm. 2021. https:\/\/doi.org\/10.1089\/cbr.2021.0294.","journal-title":"Cancer Biother Radiopharm"},{"key":"2952_CR61","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1016\/j.jbiotec.2015.04.024","volume":"208","author":"X Liang","year":"2015","unstructured":"Liang X, Potter J, Kumar S, Zou Y, Quintanilla R, Sridharan M, et al. Rapid and highly efficient mammalian cell engineering via Cas9 protein transfection. Journal of Biotechnology. 2015;208:44\u201353.","journal-title":"Journal of Biotechnology"},{"issue":"6","key":"2952_CR62","doi-asserted-by":"publisher","first-page":"3299","DOI":"10.4049\/jimmunol.1003613","volume":"186","author":"RD Michalek","year":"2011","unstructured":"Michalek RD, Gerriets VA, Jacobs SR, Macintyre AN, MacIver NJ, Mason EF, et al. Cutting edge: distinct glycolytic and lipid oxidative metabolic programs are essential for effector and regulatory CD4+ T cell subsets. J Immunol. 2011;186(6):3299\u2013303.","journal-title":"J Immunol."},{"issue":"18","key":"2952_CR63","doi-asserted-by":"publisher","first-page":"e122299","DOI":"10.1172\/jci.insight.122299","volume":"3","author":"K Pilipow","year":"2018","unstructured":"Pilipow K, Scamardella E, Puccio S, Gautam S, De Paoli F, Mazza EM, et al. Antioxidant metabolism regulates CD8+ T memory stem cell formation and antitumor immunity. JCI Insight. 2018;3(18):e122299.","journal-title":"JCI Insight."},{"key":"2952_CR64","doi-asserted-by":"publisher","first-page":"104778","DOI":"10.1016\/j.ebiom.2023.104778","volume":"95","author":"T Vaikunthanathan","year":"2023","unstructured":"Vaikunthanathan T, Landmann E, Correa DM, Romano M, Trevelin SC, Peng Q, et al. Dysregulated anti-oxidant signalling and compromised mitochondrial integrity negatively influence regulatory T cell function and viability in liver disease. EBioMedicine. 2023;95:104778.","journal-title":"EBioMedicine"},{"issue":"1","key":"2952_CR65","doi-asserted-by":"publisher","first-page":"21673","DOI":"10.1038\/s41598-020-78715-2","volume":"10","author":"A Lepez","year":"2020","unstructured":"Lepez A, Pirnay T, Denanglaire S, Perez-Morga D, Vermeersch M, Leo O, et al. Long-term T cell fitness and proliferation is driven by AMPK-dependent regulation of reactive oxygen species. Sci Rep. 2020;10(1):21673.","journal-title":"Sci Rep."},{"issue":"3","key":"2952_CR66","doi-asserted-by":"publisher","first-page":"109","DOI":"10.3960\/jslrt.17019","volume":"57","author":"M Fujisawa","year":"2017","unstructured":"Fujisawa M, Chiba S, Sakata-Yanagimoto M. Recent Progress in the Understanding of Angioimmunoblastic T-cell Lymphoma. J Clin Exp Hematop. 2017;57(3):109\u201319.","journal-title":"J Clin Exp Hematop"}],"container-title":["Journal of Experimental &amp; Clinical Cancer Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13046-024-02952-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13046-024-02952-w\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13046-024-02952-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,9]],"date-time":"2024-02-09T12:05:51Z","timestamp":1707480351000},"score":1,"resource":{"primary":{"URL":"https:\/\/jeccr.biomedcentral.com\/articles\/10.1186\/s13046-024-02952-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,2,6]]},"references-count":66,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,12]]}},"alternative-id":["2952"],"URL":"https:\/\/doi.org\/10.1186\/s13046-024-02952-w","relation":{},"ISSN":["1756-9966"],"issn-type":[{"value":"1756-9966","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,2,6]]},"assertion":[{"value":"5 October 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 January 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 February 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All mouse experimental procedures were carried out in compliance with protocols approved by the local ethical and experimentation committee (SBEA, Nice, France, autorisation N\u00b0 28790\u20132020121715244498 and B0608820).All human blood and tissues were obtained after informed consent and approval was obtained by the ethical commission of the hospitals according to the Helsinki declaration.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no conflict of interest.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"43"}}